ReviewSeminars in thrombosis and hemostasis2020
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.
Review in Seminars in thrombosis and hemostasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Physical Activity, Bleedings and Quality of Life in Subjects with Haemophilia A without Inhibitors-A Multicenter, Observational Italian Study with a Wearable Device.Journal of clinical medicine · 2024Article
- The Effects of Coronavirus Disease 2019 Pandemic on Patients with Hemophilia and Inherited Bleeding Disorders: Results from 2 Centers in Turkey.Turkish archives of pediatrics · 2023Article
- Safety of intramuscular COVID-19 vaccination in patients with haemophilia.Haemophilia : the official journal of the World Federation of Hemophilia · 2022Observational
- Severe COVID-19 Infection Management in a Patient with Mild Haemophilia-A Case Report.Hematology reports · 2022Article
- Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study.Haemophilia : the official journal of the World Federation of Hemophilia · 2021Article
- SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm.Journal of clinical medicine · 2021Review
- Mobile Health Technology for the Personalized Therapy of Hemophilia.Frontiers in medicine · 2021Review
- Management of COVID-19-associated coagulopathy in persons with haemophilia.Haemophilia : the official journal of the World Federation of Hemophilia · 2021Article
- Severe bleeding in a patient with factor XIII deficiency and COVID-19.Haemophilia : the official journal of the World Federation of Hemophilia · 2021Article
- Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations.Acta bio-medica : Atenei Parmensis · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.